FDA approves Signos glucose monitoring for weight loss | NYGazet

Any patient can access Signos' system, which uses an AI platform and an off-the-shelf continuous glucose monitor, or CGM, from Dexcom.

The Food and Drug Administration on Wednesday approved the first-ever glucose monitoring system specifically for weight loss from the startup Signos, establishing a new option for Americans to manage their weight. Current treatment options for losing... [3030 chars]